AzTrials
AzTrials

Older Adults Without Any Specific Clinical ConditionNCT05460039

Impact of a Technology Mediated Dance Intervention

A study testing Dance mediated by tecnhology in people with Older Adults Without Any Specific Clinical Condition, run by Aveiro University at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to investigate whether a technology-mediated dance impacts on psychosocial, physical and cognitive functions of the old adults when compared to usual activities. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
What is being tested?
Dance mediated by tecnhology
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 sitePortugal
Study dates
19 Jul 2022to 30 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • People living independently in the community
  • 65 years old or older
  • With no cognitive impairment defined based on the 6-item cognitive decline test [4]
  • Independent at walking without walking aids
  • Access to a personal computer and internet
  • For older adults unable to use a computer, a patient or carer with digital literacy needs to be identified for the older adult to enter the study.

Who cannot join

  • Reporting cardiovascular pathology that limits the performance of the dance or dizziness or imbalance prior to using the mat

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • School of Health Sciences

    Aveiro

Other trials in Portugal

About this study

Official title: Technology-mediated Dance: Impact on Psychossocial, Physical, and Cognitive Functions of the Old

This study aims to investigate whether a technology-mediated dance impacts on psychosocial, physical and cognitive functions of the old adults when compared to usual activities.

Read the detailed description

This study aims to investigate whether a technology-mediated dance impacts on psychosocial, physical, and cognitive functions of old adults when compared to usual activities. It will have two arms one of which will receive a dance mat and perform dance sessions for 8 weeks, while the other group will continue their usual activities. Participants will be assessed for psychosocial, physical, and cognitive aspects at baseline, end of the intervention, and at 3 months follow-up.

Being tested
Dance mediated by tecnhology

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dance mediated by tecnhologyOther

    A web system and a dance mat are used to stimulate participants to perform dance activities for 8 weeks.

Study groups in NCT05460039
Study groupRoleWhat they receive
Usual activitiesNo interventionThis group will receive no intervention.
DanceMoveExperimentalThis group will perform dance sessions mediated by technology (a dance mat and a web platform).
Receives: Other: Dance mediated by tecnhology

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gait velocity

    Assessed using the gait velocity test, i.e., the velocity of gait when walking in a straight line for 4 meters; it is measured in meters per second.

    Measured: Baseline

  2. Gait velocity

    Assessed using the gait velocity test, i.e., the velocity of gait when walking in a straight line for 4 meters; it is measured in meters per second.

    Measured: After the intervention (8 weeks after baseline assessment)

  3. Gait velocity

    Assessed using the gait velocity test, i.e., the velocity of gait when walking in a straight line for 4 meters; it is measured in meters per second.

    Measured: At 3 months follow up

Secondary outcomes (24)
  1. Balance

    Balance will be assessed through the Functional Reach Test, which measures the ability of a person to reach forward without moving the feet; it is measured in cm.

    Measured: Baseline

  2. Balance

    Balance will be assessed through the Functional Reach Test, which measures the ability of a person to reach forward without moving the feet; it is measured in cm.

    Measured: After the intervention (8 weeks after baseline assessment)

  3. Balance

    Balance will be assessed through the Functional Reach Test, which measures the ability of a person to reach forward without moving the feet; it is measured in cm.

    Measured: At 3 months follow up

  4. Cognitive functioning

    This will be measured using the Trail Making Test which is a paper-based test; score is given in seconds.

    Measured: Baseline

  5. Cognitive functioning

    This will be measured using the Trail Making Test which is a paper-based test; score is given in seconds.

    Measured: After the intervention (8 weeks after baseline assessment)

  6. Cognitive functioning

    This will be measured using the Trail Making Test which is a paper-based test; score is given in seconds.

    Measured: At 3 months follow up

  7. Pain intensity

    Measured with a 100 mm Vertical Numeric Pain Rating Scale, anchored with 0 (no pain) and 100 (worst possible pain)

    Measured: Baseline

  8. Pain intensity

    Measured with a 100 mm Vertical Numeric Pain Rating Scale, anchored with 0 (no pain) and 100 (worst possible pain)

    Measured: After the intervention (8 weeks after baseline assessment)

  9. Pain intensity

    Measured with a 100 mm Vertical Numeric Pain Rating Scale, anchored with 0 (no pain) and 100 (worst possible pain)

    Measured: At 3 months follow up

  10. Quality of life

    Measured using the WHOQOL-Bref (WHO Quality of Life questionnaire); scores range between 0 to 20 and higher scores indicate better quality of life

    Measured: Baseline

  11. Quality of life

    Measured using the WHOQOL-Bref (WHO Quality of Life questionnaire); scores range between 0 to 20 and higher scores indicate better quality of life

    Measured: After the intervention (8 weeks after baseline assessment)

  12. Quality of life

    Measured using the WHOQOL-Bref (WHO Quality of Life questionnaire); scores range between 0 to 20 and higher scores indicate better quality of life

    Measured: At 3 months follow up

  13. Health status

    Measured using the EuroQoL EQ-5D; scores range from 5 to 25 and higher scores; indicate lower quality of life (note: according to the EuroQol Research Foundation, EQ-5D is not an abbreviation and is the correct term to use in print or verbally)

    Measured: Baseline

  14. Health status

    Measured using the EuroQoL EQ-5D; scores range from 5 to 25 and higher scores; indicate lower quality of life (note: according to the EuroQol Research Foundation, EQ-5D is not an abbreviation and is the correct term to use in print or verbally)

    Measured: After the intervention (8 weeks after baseline assessment)

  15. Health status

    Measured using the EuroQoL EQ-5D; scores range from 5 to 25 and higher scores; indicate lower quality of life (note: according to the EuroQol Research Foundation, EQ-5D is not an abbreviation and is the correct term to use in print or verbally)

    Measured: At 3 months follow up

  16. Self-efficacy

    Measured using the Perceived Self-Efficacy Scale; scores vary between 10 and 40 and higher scores indicate higher self-efficacy

    Measured: Baseline

  17. Self-efficacy

    Measured using the Perceived Self-Efficacy Scale; scores vary between 10 and 40 and higher scores indicate higher self-efficacy

    Measured: After the intervention (8 weeks after baseline assessment)

  18. Self-efficacy

    Measured using the Perceived Self-Efficacy Scale; scores vary between 10 and 40 and higher scores indicate higher self-efficacy

    Measured: At 3 months follow up

  19. Loneliness

    Measured using the University of California, Los Angeles, Loneliness Scale; scores vary between 4 and 28 and higher scores indicate higher loneliness

    Measured: Baseline

  20. Loneliness

    Measured using the University of California, Los Angeles, Loneliness Scale; scores vary between 4 and 28 and higher scores indicate higher loneliness

    Measured: After the intervention (8 weeks after baseline assessment)

  21. Loneliness

    Measured using the University of California, Los Angeles, Loneliness Scale; scores vary between 4 and 28 and higher scores indicate higher loneliness

    Measured: At 3 months follow up

  22. Social support

    Measured with the Oslo Social Support Scale (OSSS-3) with Life Events Scale; score varies between 3 and 14 and higher scores indicate stronger social support

    Measured: Baseline

  23. Social support

    Measured with the Oslo Social Support Scale (OSSS-3) with Life Events Scale; score varies between 3 and 14 and higher scores indicate stronger social support

    Measured: After the intervention (8 weeks after baseline assessment)

  24. Social support

    Measured with the Oslo Social Support Scale (OSSS-3) with Life Events Scale; score varies between 3 and 14 and higher scores indicate stronger social support

    Measured: At 3 months follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jul 2022
  2. Study start19 Jul 2022
  3. Primary completion30 Nov 2023
  4. Study completion30 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05460039
Sponsor's protocol ID
DanceMove
Status last verified
Feb 2024
First submitted
14 Jul 2022
Last updated
6 Feb 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Silva AG, Martins AI, Andias R, Nery E, Silva T, Ribeiro O, Santinha G, Rocha NP. A web step-based digital solution's impact on physical, cognitive and psychosocial functioning of community-dwelling older adults: A mixed methods randomized and controlled trial. Internet Interv. 2024 Aug 21;38:100766. doi: 10.1016/j.invent.2024.100766. eCollection 2024 Dec.

    PubMed 39280041

Questions about this trial

What is this clinical trial studying?

A study testing Dance mediated by tecnhology in people with Older Adults Without Any Specific Clinical Condition, run by Aveiro University at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gait velocity (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05460039, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in